Laura A. Levit

2 weeks ago | ascopubs.org | Joseph M. Unger |Hillary Andrews |Laura A. Levit

1-3 Given the challenges of recruiting patients to clinical trials during a pandemic, major federal agencies shared guidance to allow more flexibility in trial processes, supporting the continuity of clinical trials while ensuring patient safety and data integrity.4,5 Trial sponsors rapidly adopted these measures, including strategies such as remote patient consent to participate, remote symptom monitoring, and distribution of oral anticancer agents directly to trial patients.4-6 Enrollment...

Sep 26, 2024 | brnw.ch | Laura A. Levit |Patricia Ganz

SPECIAL ARTICLES BackgroundIn 2012, the National Academies of Sciences, Engineering, and Medicine (NASEM) convened a committee charged with addressing the quality of cancer care in the United States and providing recommendations to policymakers and the cancer care community on strategies to improve cancer care delivery from the time of diagnosis through end of life.